Serine/Threonine-Protein Kinase MARK1 (MARK1) Antibody

Product Graph
357.5€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Serine/Threonine-Protein Kinase MARK1 (MARK1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx145448
tested applications
ELISA, WB, IHC

Description

MARK1 Antibody is a Rabbit Polyclonal against MARK1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetSerine/Threonine-Protein Kinase MARK1 (MARK1)
HostRabbit
ReactivityHuman
Recommended DilutionELISA: 1/20000 - 1/80000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
IsotypeIgG
PurificationPurified by antigen affinity column chromatography.
Size 1100 µg
Size 21 mg
FormLyophilized
Tested ApplicationsELISA, WB, IHC
BufferPrior to lyophilization: 1% BSA and 0.02% NaN3.
AvailabilityShipped within 7-15 working days.
StorageStore at -20 °C. Avoid repeated freeze/thaw cycles.
Dry IceNo
NCBI AccessionBC113869
BackgroundAntibody anti-MARK1
StatusRUO
NoteConcentration: Lyophilized form: Not applicable. After reconstitution: 1 mg/ml. -

Descripción

Related Products

FNab05012

anti- MARK1 antibody

Ver Producto
abx005835

Serine/Threonine-Protein Kinase MARK1 (MARK1) Antibody

MARK1 Antibody is a Rabbit Polyclonal Antibody against MARK1.

Ver Producto
abx025118

Serine/Threonine-Protein Kinase MARK1 (MARK1) Antibody

MARK is a family of kinases that is known for its involvement in establishing cell polarity and in phosphorylating tau protein during Alzheimer neurodegeneration. Expression of MARK causes the phosphorylation of MAPs at their KXGS motifs, thereby detaching MAPs from the microtubules and thus facilitating the transport of particles. This occurs without impairing the intrinsic activity of motors because the velocity during active movement remains unchanged. In primary retinal ganglion cells, transfection with tau leads to the inhibition of axonal transport of mitochondria, APP vesicles, and other cell components which leads to starvation of axons and vulnerability against stress. This transport inhibition can be rescued by phosphorylating tau with MARK.

Ver Producto